OrbiMed’s SEQUENOM INC NEW SQNM Stock Holding History

OrbiMed’s Portfolio SQNM Stock Details SQNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-3,603,000	Closed	-$15.2M	–	142
2013 Q2	$15.2M	Buy	+3,603,000	New	+$14.4M	0.32%	60

Other funds holding SQNM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CII

CR Intrinsic Investors Stamford, Connecticut $2.67B AUM 28.43% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OrbiMed's SQNM Position: Q3 2013 in Review

OrbiMed sold out of SEQUENOM INC NEW (SQNM) in Q3 2013, closing a stake of 3,603,000 shares — an estimated $15.2M sold.

OrbiMed first reported a position in SQNM in Q2 2013 and held it in 1 quarter. The position peaked at $15.2M in Q2 2013. 126 funds tracked by Wall St. Rank hold SQNM as of Q3 2013.

OrbiMed reported no remaining SEQUENOM INC NEW position as of Q3 2013 after selling out during the quarter.
OrbiMed sold 3,603,000 SEQUENOM INC NEW shares in Q3 2013, an estimated $15.2M.
OrbiMed first reported a position in SEQUENOM INC NEW in Q2 2013 and held it in 1 quarter.
OrbiMed's SEQUENOM INC NEW position peaked at $15.2M in Q2 2013.
126 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q3 2013.

Based on OrbiMed's 13F filing for Q3 2013, filed 14 Nov 2013.